Product Description
Overall, the total global breast implant market was valued at slightly over $2 billion in 2022. This is expected to increase over the forecast period at a CAGR of 5.0% to reach nearly $2.9 billion.
The full report suite on the global market for breast implants is further segmented into product type and implant shape. Within the product type segmentation, the market covers saline and silicone breast implants. The silicone breast implant market is further segmented into smooth and textured silicone breast implant markets. The global breast implant market is analyzed in terms of units sold by implant shape, segmented into round implant and anatomical implant segments.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL BREAST IMPLANT MARKET INSIGHTS
The growth in the breast implant market is limited by the risks associated with breast procedures. The correlation between textured implants and breast-implant-associated anaplastic large cell lymphoma (BIA-ALCL), closely studied in the past, resulted in a massive product recall in 2019. This was also combined with the decline in elective procedures during COVID-19 in the following year, resulting in slow but steady recovery over the forecast period.
GLOBAL BREAST IMPLANT MARKET SHARE INSIGHTS
The global dermal filler market was dominated by Mentor Corporation, Allergan, and Polytech. 
Mentor Corporation, a Johnson & Johnson company, led the global breast implant market in 2022. The company offers both silicone and saline implants under its Mentor® product line. In January 2022, Mentor received the U.S. Food and Drug Administration (FDA) approval for its Mentor® MemoryGel BOOST™ breast implant.
MARKET SEGMENTATION SUMMARY
- Saline Breast Implant Market
- Silicone Breast Implant Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
